Login to Your Account

Wizards of osseous: Bone drugs via Amgen, Radius stacked as readout nears

By Randy Osborne
Staff Writer

Friday, January 29, 2016

Amgen Inc.'s investor-pleasing fourth quarter and full 2015 earnings won the customary nods from analysts, who promptly zeroed in on the next major milestone.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription